User profiles for P. Schmid

Peter Schmid

- Verified email at qmul.ac.uk - Cited by 26432

Peter Schmid

- Verified email at kaust.edu.sa - Cited by 20436

Philipp Schmid

- Verified email at ru.nl - Cited by 5135

[HTML][HTML] The psychological drivers of misinformation belief and its resistance to correction

…, P Schmid, LK Fazio, N Brashier, P Kendeou… - Nature Reviews …, 2022 - nature.com
Misinformation has been identified as a major contributor to various contentious contemporary
events ranging from elections and referenda to the response to the COVID-19 pandemic. …

Stability and transition in shear flows. applied mathematical sciences, vol. 142

PJ Schmid, DS Henningson… - Appl. Mech …, 2002 - asmedigitalcollection.asme.org
This monograph consists of seven lectures, written by nine specialists of geotechnique,
emphasizing their fields of interest and thought as an advanced course to engineering students …

Nonmodal stability theory

PJ Schmid - Annu. Rev. Fluid Mech., 2007 - annualreviews.org
Hydrodynamic stability theory has recently seen a great deal of development. After being
dominated by modal (eigenvalue) analysis for many decades, a different perspective has …

[HTML][HTML] Trastuzumab deruxtecan in previously treated HER2-low advanced breast cancer

…, SB Kim, Q Liu, T Luo, C Saura, P Schmid… - … England Journal of …, 2022 - Mass Medical Soc
… for disease progression or death, 0.50; P<0.001), and overall survival was 23.4 months and
16.8 months, respectively (hazard ratio for death, 0.64; P=0.001). Adverse events of grade 3 …

[HTML][HTML] Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer

P Schmid, S Adams, HS Rugo… - … England Journal of …, 2018 - Mass Medical Soc
Background Unresectable locally advanced or metastatic triple-negative (hormone-receptor–negative
and human epidermal growth factor receptor 2 [HER2]–negative) breast cancer is …

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer …

…, S Loi, Z Guo, J Zhao, G Aktan, V Karantza, P Schmid… - The Lancet, 2020 - thelancet.com
Background Pembrolizumab monotherapy showed durable antitumour activity and manageable
safety in patients with metastatic triple-negative breast cancer. We aimed to examine …

[HTML][HTML] Event-free survival with pembrolizumab in early triple-negative breast cancer

P Schmid, J Cortes, R Dent, L Pusztai… - … England Journal of …, 2022 - Mass Medical Soc
Background The addition of pembrolizumab to neoadjuvant chemotherapy led to a
significantly higher percentage of patients with early triple-negative breast cancer having a …

Dynamic mode decomposition of numerical and experimental data

PJ Schmid - Journal of fluid mechanics, 2010 - cambridge.org
The description of coherent features of fluid flow is essential to our understanding of fluid-dynamical
and transport processes. A method is introduced that is able to extract dynamic …

[HTML][HTML] Pembrolizumab for early triple-negative breast cancer

P Schmid, J Cortes, L Pusztai, H McArthur… - … England Journal of …, 2020 - Mass Medical Soc
Background Previous trials showed promising antitumor activity and an acceptable safety
profile associated with pembrolizumab in patients with early triple-negative breast cancer. …

Electrical and optical properties of TiO2 anatase thin films

H Tang, K Prasad, R Sanjines, PE Schmid… - Journal of applied …, 1994 - pubs.aip.org
Electrical and optical spectroscopic studies of TiO 2 anatase thin films deposited by sputtering
show that the metastable phase anatase differs in electronic properties from the well‐…